Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 5000.00 | 3570.27 | 6414.00 | 6353.50 | 1.0095 | 1.0229 |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 5000.00 | 3570.27 | 5952.00 | 6353.50 | 0.9368 | 0.8490 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 6344.00 | 6353.50 | 0.9985 | 0.9964 | |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 6099.00 | 6353.50 | 0.9599 | 0.9041 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 5000.00 | 3570.27 | 4132.00 | 6353.50 | 0.6504 | 0.1921 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 5000.00 | 3570.27 | 5403.00 | 6353.50 | 0.8504 | 0.6459 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 5000.00 | 3570.27 | 6123.00 | 6353.50 | 0.9637 | 0.9131 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 5000.00 | 3570.27 | 6318.00 | 6353.50 | 0.9944 | 0.9866 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 5000.00 | 3570.27 | 6373.00 | 6353.50 | 1.0031 | 1.0074 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 5000.00 | 3570.27 | 3968.00 | 6353.50 | 0.6245 | 0.1354 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 6382.00 | 6353.50 | 1.0045 | 1.0108 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 5000.00 | 3570.27 | 6410.00 | 6353.50 | 1.0089 | 1.0214 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 6504.00 | 6353.50 | 1.0237 | 1.0571 | |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 5000.00 | 3570.27 | 6622.00 | 6353.50 | 1.0423 | 1.1021 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 5000.00 | 3570.27 | 3273.00 | 6353.50 | 0.5152 | -0.0993 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 5000.00 | 3570.27 | 5656.00 | 6353.50 | 0.8902 | 0.7390 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 3018.00 | 6353.50 | 0.4750 | -0.1830 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 3057.00 | 6353.50 | 0.4812 | -0.1703 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 5000.00 | 3570.27 | 6429.00 | 6353.50 | 1.0119 | 1.0286 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 6308.00 | 6353.50 | 0.9928 | 0.9828 | |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 5000.00 | 3570.27 | 3241.00 | 6353.50 | 0.5101 | -0.1099 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 4865.00 | 6353.50 | 0.7657 | 0.4508 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 5000.00 | 3570.27 | 6174.00 | 6353.50 | 0.9718 | 0.9322 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 4023.00 | 6353.50 | 0.6332 | 0.1544 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 6376.00 | 6353.50 | 1.0035 | 1.0085 |